TheMachine Press

A daily newspaper for the age of artificial intelligence.

Morning edition

Permanent story

research

Gonorrhea Treatment Is Moving Past One Size Fits All

A new journal supplement calls for rapid resistance tests, local surveillance, and a broader treatment arsenal.

Published Updated Story ID: mp-2026-07-23-018
Read the complete editionStory JSON

Summary

A new journal supplement calls for rapid resistance tests, local surveillance, and a broader treatment arsenal.

UCLA clinicians note that resistance has defeated every former first-line antibiotic. New tests and two recently approved therapies create options, but access and stewardship remain central.

Why it matters

A new journal supplement calls for rapid resistance tests, local surveillance, and a broader treatment arsenal.

Limits and context

  • New tests and two recently approved therapies create options, but access and stewardship remain central.

Key claims

  1. A new journal supplement calls for rapid resistance tests, local surveillance, and a broader treatment arsenal.

    Qualification: New tests and two recently approved therapies create options, but access and stewardship remain central.

    Evidence: source-2026-07-23-020

Sources

  1. UCLA Health via Newswise: Drug-resistant gonorrhea strategyUCLA Health via Newswise · secondary reporting

Corrections

No corrections have been recorded for this story.